Diastolic Dysfunction and TAVR: Prognosis before and after Procedure

The PARTNER 2 SAPIEN 3 showed baseline diastolic dysfunction is a predictor of clinical events after 2 years of TAVR. As expected, improved diastolic function after procedure immediately changes prognosis. 

Función diastólica y TAVI

Though these outcomes did meet our expectations, very few studies have shown hard evidence linking diastolic dysfunction and aortic stenosis. 

All patients included in the PARTNER 2 SAPIEN 3 registry received an echocardiogram at baseline, at 30 days, one, and two years, to look into diastolic dysfunction, and were classified according to the American Society of Echocardiography diastolic dysfunction groups. 

Of 1750 patients in the registry, 682 (54.4%) showed diastolic dysfunction grade 1, 352 (28.1%) had grade 2 and 168 (13.4%) had grade 3. The rest of patients (4.1%) were undetermined.  

Diastolic dysfunction grade was associated to increased death and hospitalization at 1 and 2 years (p<0.002) and all cause death at 2 years (p=0.01).


Read also: Last Bastion of Bare Metal Stents Finally Falls.


70.8% of patients showed improved diastolic function after valve implantation. Those who showed at least one grade improvement in calcification after procedure showed reduced mortality and hospitalization rates at one year (p<0.001) and increased survival rate at 2 years (p=0.01).

A simple transthoracic echocardiogram 30 days after procedure can provide information on hard points at mid and long -term. 

Conclusion

The PARTNER 2 SAPIEN 3 has shown that baseline diastolic dysfunction, and its improvement after TAVR, can predict hard events at 2 years, including death. 

j-jacc-2020-10-032free

Original Title: Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement PARTNER 2 SAPIEN 3 Registry.

Reference: Geraldine Ong et al. J Am Coll Cardiol 2020;76:2940–51. https://doi.org/10.1016/j.jacc.2020.10.032


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

FRANCE TAVI Registry: Coronary Adverse Events After TAVI

Between 30% and 70% of patients undergoing transcatheter aortic valve implantation (TAVI) have coronary artery disease (CAD). However, the prognostic impact of CAD in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...